St. Joseph's HPV Self-sampling for Cervical Cancer Screening
This study at St. Joseph's aims to see if offering a self-sampling option for HPV (human papillomavirus) testing can encourage more women to get screened for cervical cancer. You might be able to join if you are a woman between 30 and 65 years old, are due for cervical cancer screening, and are not at a higher-than-average risk for cervical cancer. The study is looking at how many people choose the self-sampled HPV test (using the Evalyn Self-Sampling Brush) versus the standard test done by a doctor, and how many complete the self-sampled test. The current status of this study is unclear, and it plans to enroll 50 participants.
- Study design
- This study is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 50 participants.
- What's involved
- If you choose the self-sampled HPV test, you will be given a kit to collect your sample at home and mail it back. You will also fill out a form with your personal information.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will measure how many patients request and complete the self-sampled HPV test up to 12 months after enrollment begins, and completion of the self-sampled test within 1 month of receiving it.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Christina Scartozzi, DO · PRINCIPAL_INVESTIGATOR · Penn State College of Medicine
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of patients who request the self-sampled HPV test12 months after enrollment begins
This outcome is measuring the number of patients who select to receive a self-sampled HPV test out of all patients presented with the research opportunity. The results will be presented as the acceptance rate of the self-sampled HPV test. The measurement tool for this outcome is a patient-completed questionnaire where the patient can request 1) a self-sampled HPV test, 2) a clinician-sampled test, or 3) to not receive their cervical cancer screening at this time.
- Number of patients who request the clinician-sampled test12 months after enrollment begins
This outcome is measuring the number of patients who select to receive a clinician-sampled cervical cancer screening out of all patients presented with the research opportunity. The results will be presented as the acceptance rate of the clinician-sampled test. The measurement tool for this outcome is a patient-completed questionnaire where the patient can request 1) a self-sampled HPV test, 2) a clinician-sampled test, or 3) to not receive their cervical cancer screening at this time.
- Number of patients who complete the self-sampled HPV test1 month after patient is given self-sampled HPV test
This outcome is measuring the number of patients who complete and return the self-sampled HPV test out of all the patients who receive a self-sampled HPV test. A patient will have up to one month to complete and return the self-sampled HPV test. The final outcome results will be calculated one month after the last patient receives a self-sampled HPV test.